title: US consumer group criticizes proposal to allow drug makers to challenge safety information.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D004345:Drug Industry; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D017712:Peer Review, Research; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration